29 November 2018 1 Min Read
Bayer sells assets and cuts jobs as it takes impairment charge
CEO is under pressure to boost share price, dragged lower by concern over lawsuits due to alleged cancer-causing Monsanto weedkiller Roundup
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In